SCHEMBL8446237

SCHEMBL8446237

CC(=O)Nc1nc(Cl)c(NC=O)c(NC2C=CC(CO)C2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8446236 1.00
SCHEMBL9842434 1.00
SCHEMBL330795 0.89 CDK5 (0.31)
SCHEMBL7668284 0.83 NR1I2 (0.37)
SCHEMBL14048880 0.83 NR1I2 (0.37)
SCHEMBL331086 0.83 NR1I2 (0.37)
SCHEMBL14049050 0.83 NR1I2 (0.37)
SCHEMBL4980169 0.83 NR1I2 (0.37)
SCHEMBL6322977 0.77
SCHEMBL8109272 0.73 L3MBTL1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0434450-B1 Therapeutic nucleosides WELLCOME FOUND (GB) 1999-07-07 EP disclosed
EP-0921121-A1 Intermediates to therapeutic nucleosides THE WELLCOME FOUNDATION LIMITED (GB) 1999-06-09 EP disclosed
EP-0921114-A1 Intermediates to therapeutic nucleosides THE WELLCOME FOUNDATION LIMITED (GB) 1999-06-09 EP disclosed
US-5089500-A Viricides; hepatitis, aids BURROUGHS WELLCOME CO. (US) 1992-02-18 US disclosed
US-5087697-A Aids, viricides BURROUGHS WELLCOME CO. (US) 1992-02-11 US disclosed
US-5034394-A Therapeutic nucleosides BURROUGHS WELLCOME CO. (US) 1991-07-23 US disclosed
EP-0434450-A2 Therapeutic nucleosides THE WELLCOME FOUNDATION LIMITED (GB) 1991-06-26 EP disclosed